REQUEST A DEMO
Total
USD $0.00
Search more companies

Fitofarm Jsco (Ukraine)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Fitofarm Jsco Profile Updated: September 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Fitofarm Jsco is a company in Ukraine, with a head office in Kyiv. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on July 27, 1995. Fitofarm Jsco currently employs 98 (2024) people. There was a net sales revenue drop of 11.39% reported in Fitofarm Jsco’s latest financial highlights for 2024. During that time, Fitofarm Jsco’s total assets decreased by 6.61%. The net profit margin of Fitofarm Jsco decreased by 0.2% in 2024.

Headquarters
12 Vul. Almatynska
Kyiv; Kiev; Postal Code: 02092

Contact Details: Purchase the Fitofarm Jsco report to view the information.

Website: http://fitofarm.ua

Basic Information
Total Employees:
Purchase the Fitofarm Jsco report to view the information.
Outstanding Shares:
Purchase the Fitofarm Jsco report to view the information.
Registered Capital:
Purchase the Fitofarm Jsco report to view the information.
Financial Auditors:
Purchase the Fitofarm Jsco report to view the information.
Incorporation Date:
July 27, 1995
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Fitofarm Jsco report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
-11.39%
Total Operating Revenue
-12.83%
Operating Profit
4.85%
EBITDA
5.91%
Net Profit/Loss for the Period
-19.06%
Total Assets
-6.61%
Total Equity
6.35%
Operating Profit Margin
1.78%
Net Profit Margin
-0.2%
Return on Equity (ROE)
-1.87%
Debt / Equity
43.99%
Quick Ratio
0.24%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?